- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 25/22 - Anxiolytics
Patent holdings for IPC class A61P 25/22
Total number of patents in this class: 2318
10-year publication summary
|
59
|
60
|
78
|
140
|
198
|
169
|
200
|
238
|
200
|
66
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| AstraZeneca AB | 3042 |
54 |
| Takeda Pharmaceutical Company Limited | 2961 |
52 |
| Taisho Pharmaceutical Co., Ltd. | 844 |
47 |
| F. Hoffmann-La Roche AG | 7958 |
38 |
| Hoffmann-La Roche Inc. | 3060 |
29 |
| H. Lundbeck A/S | 1252 |
29 |
| Banyu Pharmaceutical Co., Ltd. | 107 |
22 |
| Janssen Pharmaceutica N.V. | 3839 |
21 |
| Société des Produits Nestlé S.A. | 9672 |
20 |
| Intra-Cellular Therapies, Inc. | 378 |
19 |
| Sumitomo Pharma Co., Ltd. | 626 |
19 |
| Daiichi Sankyo Company, Limited | 1829 |
17 |
| Nippon Chemiphar Co., Ltd. | 233 |
17 |
| Sage Therapeutics, Inc. | 312 |
17 |
| Sumitomo Dainippon Pharma Co., Ltd. | 226 |
17 |
| Les Laboratoires Servier | 599 |
16 |
| Glaxo Group Limited | 4496 |
15 |
| The Trustees of Columbia University in the City of New York | 3440 |
14 |
| Bionomics Limited | 90 |
14 |
| Eisai R&D Management Co., Ltd. | 1304 |
14 |
| Other owners | 1827 |